| Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin RL Carhart-Harris, D Erritzoe, T Williams, JM Stone, LJ Reed, A Colasanti, ... Proceedings of the National Academy of Sciences 109 (6), 2138-2143, 2012 | 1448 | 2012 |
| Glutamate and dopamine in schizophrenia: An update for the 21st century O Howes, R McCutcheon, J Stone Journal of psychopharmacology 29 (2), 97-115, 2015 | 997 | 2015 |
| Opposite effects of Δ-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology S Bhattacharyya, PD Morrison, P Fusar-Poli, R Martin-Santos, ... Neuropsychopharmacology 35 (3), 764-774, 2010 | 901 | 2010 |
| Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment A Englund, PD Morrison, J Nottage, D Hague, F Kane, S Bonaccorso, ... Journal of psychopharmacology 27 (1), 19-27, 2013 | 576 | 2013 |
| Glutamate and dopamine dysregulation in schizophrenia—a synthesis and selective review JM Stone, PD Morrison, LS Pilowsky Journal of psychopharmacology 21 (4), 440-452, 2007 | 548 | 2007 |
| Perturbations in gut microbiota composition in psychiatric disorders: a review and meta-analysis VL Nikolova, MRB Smith, LJ Hall, AJ Cleare, JM Stone, AH Young JAMA psychiatry 78 (12), 1343-1354, 2021 | 499 | 2021 |
| Complex I inhibitors induce dose‐dependent apoptosis in PC12 cells: relevance to Parkinson's disease A Hartley, JM Stone, C Heron, JM Cooper, AHV Schapira Journal of neurochemistry 63 (5), 1987-1990, 1994 | 461 | 1994 |
| Antipsychotic treatment resistance in schizophrenia associated with elevated glutamate levels but normal dopamine function A Demjaha, A Egerton, RM Murray, S Kapur, OD Howes, JM Stone, ... Biological psychiatry 75 (5), e11-e13, 2014 | 397 | 2014 |
| First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients LS Pilowsky, RA Bressan, JM Stone, K Erlandsson, RS Mulligan, ... Molecular psychiatry 11 (2), 118-119, 2006 | 354 | 2006 |
| Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine-induced psychopathology JM Stone, C Dietrich, R Edden, MA Mehta, S De Simoni, LJ Reed, ... Molecular psychiatry 17 (7), 664-665, 2012 | 322 | 2012 |
| Neuroanatomical abnormalities that predate the onset of psychosis: a multicenter study A Mechelli, A Riecher-Rössler, EM Meisenzahl, S Tognin, SJ Wood, ... Archives of general psychiatry 68 (5), 489-495, 2011 | 295 | 2011 |
| Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis RL Carhart-Harris, R Leech, D Erritzoe, TM Williams, JM Stone, J Evans, ... Schizophrenia bulletin 39 (6), 1343-1351, 2013 | 292 | 2013 |
| Glutamate dysfunction in people with prodromal symptoms of psychosis: relationship to gray matter volume JM Stone, F Day, H Tsagaraki, I Valli, MA McLean, DJ Lythgoe, ... Biological psychiatry 66 (6), 533-539, 2009 | 289 | 2009 |
| The blood–brain barrier in psychosis TA Pollak, S Drndarski, JM Stone, AS David, P McGuire, NJ Abbott The Lancet Psychiatry 5 (1), 79-92, 2018 | 288 | 2018 |
| Evidence-based guidelines for the pharmacological treatment of schizophrenia: updated recommendations from the British Association for Psychopharmacology TRE Barnes, R Drake, C Paton, SJ Cooper, B Deakin, IN Ferrier, ... Journal of Psychopharmacology 34 (1), 3-78, 2020 | 259 | 2020 |
| Treatment-resistant schizophrenia patients show elevated anterior cingulate cortex glutamate compared to treatment-responsive E Mouchlianitis, MAP Bloomfield, V Law, K Beck, S Selvaraj, N Rasquinha, ... Schizophrenia bulletin 42 (3), 744-752, 2016 | 259 | 2016 |
| Anterior cingulate glutamate levels related to clinical status following treatment in first-episode schizophrenia A Egerton, S Brugger, M Raffin, GJ Barker, DJ Lythgoe, PK McGuire, ... Neuropsychopharmacology 37 (11), 2515-2521, 2012 | 228 | 2012 |
| Functional neuroimaging in schizophrenia: diagnosis and drug discovery P McGuire, OD Howes, J Stone, P Fusar-Poli Trends in pharmacological sciences 29 (2), 91-98, 2008 | 197 | 2008 |
| Ketamine: a tale of two enantiomers LA Jelen, AH Young, JM Stone Journal of Psychopharmacology 35 (2), 109-123, 2021 | 190 | 2021 |
| Drug models of schizophrenia H Steeds, RL Carhart-Harris, JM Stone Therapeutic advances in psychopharmacology 5 (1), 43-58, 2015 | 190 | 2015 |
David J LythgoeKing's College Londonkcl.ac.uk의 이메일 확인됨
